2019
DOI: 10.1101/19006783
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Hidden heterogeneity and its influence on dengue vaccination impact

Abstract: The CYD-TDV vaccine was recently developed to combat dengue, a mosquito-borne viral disease that afflicts millions of people each year throughout the tropical and subtropical world. Its rollout has been complicated by recent findings that vaccinees with no prior exposure to dengue virus (DENV) experience an elevated risk of severe disease in response to their first DENV infection subsequent to vaccination. As a result of these findings, guidelines for use of CYD-TDV now require serological screening prior to v… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 55 publications
(90 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?